Table 1.

Summary of antibodies used for flow cytometry to their specifications. BioLegend (BL), Beckman Coulter (BC), Caltag (C), BD Pharming (BD), eBioscience (eB), Sigma-Aldrich (SA). Mesenchymal marker (MM), endothelial marker (EM), haemopoietic marker (HM), adhesion molecule (AM), proliferation marker (PM)

		Clone	Function
CD29	BL	TS2/16	MM, b1 integrin, associates with CD49a in VLA-1 integrin
CD31	BL	WM59	EM, PECAM-1, tissue regeneration and safely removing neutrophils
CD34	BC	581	HM, HPCA1, expression on early hematopoietic and vascular-associated tissue
CD44	C	MEM-85	MM, binds hyaluronic acid, mediates adhesion of stromal cells and ECM
CD45	C	HI30	HM, protein tyrosine phosphatase, receptor type C
CD49d	BC	HP2/1	AM, VLA-4, a4 integrin, associates with CD29, binds fibronectin, VCAM-1, adhesion
CD49e	BC	SAM-1	AM, VLA-5, a5 integrin, associates with CD29, binds fibronectin, adhesion, apoptosis
CD71	BL	MEM-75	PM, transferrin receptor 1 controls iron uptake during cell proliferaion
CD73	BD	AD2	MM, ecto-5-nucleotidase, dephosphorylates nucleotides to allow nucleoside uptake
CD90	BC	F15-42-1-5	MM, Thy-1, possible inhibition of stem cell and neuron differentiation
CD105	BL	MEM-226	MM, EM, endoglin, protective role against pro-apoptotic factors
CD106	BL	STA	EM, VCAM-1, adhesion of cells to vascular endothelium
CD146	BC	TEA1/34	EM, MCAM, mesenchymal stem cells with greater differentiation potential
CD166	BC	3A6	MM, AM, ALCAM, ligand for CD6
CD184	C	12 G5	MM, HM, CXCR4, alpha-chemokine receptor specific for stromal-derived-factor-1
CD197	eB	3D12	Chemokine, CCR7
CD222	eB	MEM-238	PM, receptor for insulin-like growth factor 2
HLA-I	C	Tu149	Major histocompatibility class I
HLA-II	C	Tu36	Major histocompatibility class II
FSH-R	SA	F3929	PM, receptor FSH, GCs are the only cell type expressing the FSH-R
LH-R	SA	L6792	receptor LH, luteinization GCs